We are live on
!
Find out more
JAM
JW Asset Management Portfolio holdings
AUM
$244M
1-Year Est. Return
71.51%
This Fund
S&P 500
This Quarter
Est. Return
-2.22%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$221M
AUM Growth
-$21.2M
(-8.7%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
99.57%
Holding
17
New
4
Increased
2
Reduced
1
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viking Therapeutics
VKTX
|
+$2.64M |
| 2 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$1.86M |
| 3 |
NVIDIA
NVDA
|
+$1.3M |
| 4 |
Alibaba
BABA
|
+$1.23M |
| 5 |
Five Below
FIVE
|
+$421K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$9.73M |
| 2 |
Eli Lilly
LLY
|
+$7.7M |
| 3 |
Hims & Hers Health
HIMS
|
+$1.31M |
| 4 |
Vita Coco
COCO
|
+$531K |
| 5 |
Aspen Aerogels
ASPN
|
+$358K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.52% |
| 2 | Technology | 16.02% |
| 3 | Consumer Discretionary | 5.17% |
| 4 | Consumer Staples | 3.78% |
| 5 | Materials | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$2.7B
| $138M | 62.37% |
3,192,485
| – | – |
|
|
2
NVIDIA
NVDA
$4.77T
| $35.5M | 16.02% |
292,250
+11,000
| +4% | +$1.3M |
|
3
Abercrombie & Fitch
ANF
$4.58B
| $9.11M | 4.11% |
65,090
| – | – |
|
|
4
Vita Coco
COCO
$3.97B
| $8.37M | 3.78% |
295,621
-20,000
| -6% | -$531K |
|
|
CPRX
5
DELISTED
Catalyst Pharmaceutical
CPRX
| $8.22M | 3.71% |
413,392
| – | – |
|
|
6
AdvisorShares Pure US Cannabis ETF
MSOS
$830M
| $7.84M | 3.54% |
1,093,369
+261,086
| +31% | +$1.86M |
|
7
Heron Therapeutics
HRTX
$92M
| $4.56M | 2.06% |
2,292,418
| – | – |
|
8
Idaho Strategic Resources
IDR
$456M
| $4.37M | 1.97% |
271,697
| – | – |
|
|
9
Viking Therapeutics
VKTX
$3.93B
| $2.85M | 1.29% |
+45,000
| New | +$2.64M |
|
|
10
Alibaba
BABA
$276B
| $1.59M | 0.72% |
+15,000
| New | +$1.23M |
|
|
11
Five Below
FIVE
$11.5B
| $442K | 0.2% |
+5,000
| New | +$421K |
|
|
BBBY
12
Bed Bath & Beyond
BBBY
$503M
| $302K | 0.14% |
+33,000
| New | +$340K |
|
|
HITI
13
High Tide
HITI
$181M
| $209K | 0.09% |
102,144
| – | – |
|
|
14
Aspen Aerogels
ASPN
$364M
| – | – |
-15,000
| Closed | -$358K |
|
|
15
Hims & Hers Health
HIMS
$6.79B
| – | – |
-65,000
| Closed | -$1.31M |
|
|
16
Eli Lilly
LLY
$1.09T
| – | – |
-8,500
| Closed | -$7.7M |
|
|
NVO
17
Novo Nordisk
NVO
$225B
| – | – |
-68,200
| Closed | -$9.73M |
|
Similar funds
SC
HCM
SC
HBS
GIM
IFO
VG
CP
JW Asset Management's Q3 2024 Portfolio in Review
As of Q3 2024, JW Asset Management held 17 positions worth $221M, down 8.7% from $243M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
JW Asset Management withdrew a net $11.8M in Q3 2024, closing 4 positions and reducing 1 holding. Its most notable exit was Novo Nordisk, an estimated $9.73M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 74% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, JW Asset Management opened a new position in Viking Therapeutics worth $2.85M.
- JW Asset Management's largest Q3 2024 buy was Viking Therapeutics: 45,000 shares worth $2.85M.
- JW Asset Management added most to AdvisorShares Pure US Cannabis ETF in Q3 2024, an estimated $1.86M increase.
- JW Asset Management's biggest Q3 2024 reduction was Vita Coco, cutting an estimated $531K.
- JW Asset Management fully exited Novo Nordisk in Q3 2024, selling an estimated $9.73M.
- JW Asset Management's ten largest holdings make up 100% of its $221M portfolio in Q3 2024.
- JW Asset Management opened 4 new positions and closed 4 in Q3 2024.
- JW Asset Management's portfolio value fell 8.7% quarter-over-quarter to $221M.
Based on JW Asset Management's 13F filing for Q3 2024, filed 8 Nov 2024.